FC

Finepoint Capital Portfolio holdings

AUM $504M
This Quarter Return
+16.54%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$304M
AUM Growth
+$304M
Cap. Flow
-$22.1M
Cap. Flow %
-7.28%
Top 10 Hldgs %
63.35%
Holding
64
New
3
Increased
5
Reduced
7
Closed
7

Top Buys

1
ARVN icon
Arvinas
ARVN
$17.8M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$15.2M
3
TVTX icon
Travere Therapeutics
TVTX
$11M
4
SWTX
SpringWorks Therapeutics
SWTX
$8.79M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
$6.61M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$15.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
$15.1M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.1M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
$12.1M
5
PRTA icon
Prothena Corp
PRTA
$9.22M

Sector Composition

1 Healthcare 86.74%
2 Materials 7.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TVTX icon
1
Travere Therapeutics
TVTX
$1.56B
$25.4M 8.34% 1,028,875 +444,575 +76% +$11M
ASTL icon
2
Algoma Steel
ASTL
$511M
$23.9M 7.87% 3,716,732 – –
PRTA icon
3
Prothena Corp
PRTA
$441M
$18.5M 6.09% 305,400 -152,100 -33% -$9.22M
CYTK icon
4
Cytokinetics
CYTK
$4.23B
$18.4M 6.07% 380,793 -38,640 -9% -$1.87M
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$4.38B
$18.2M 5.98% 1,111,030 +403,830 +57% +$6.61M
APLS icon
6
Apellis Pharmaceuticals
APLS
$3.48B
$18.2M 5.98% 266,090 -52,310 -16% -$3.57M
ARVN icon
7
Arvinas
ARVN
$568M
$17.8M 5.84% +399,000 New +$17.8M
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$17.7M 5.83% 987,600 – –
FOLD icon
9
Amicus Therapeutics
FOLD
$2.34B
$17.6M 5.8% 1,688,400 -322,500 -16% -$3.37M
RCUS icon
10
Arcus Biosciences
RCUS
$1.13B
$16.9M 5.56% 646,586 +111,586 +21% +$2.92M
SAGE
11
DELISTED
Sage Therapeutics
SAGE
$16.8M 5.53% 429,313 -46,287 -10% -$1.81M
GLPG icon
12
Galapagos
GLPG
$2.07B
$16.2M 5.32% 379,702 +120,302 +46% +$5.13M
IOVA icon
13
Iovance Biotherapeutics
IOVA
$807M
$15.2M 5% 1,586,043 +625,843 +65% +$6M
CERE
14
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$15.2M 4.99% +536,901 New +$15.2M
ASND icon
15
Ascendis Pharma
ASND
$11.8B
$12.7M 4.19% 123,400 -36,100 -23% -$3.73M
ARGX icon
16
argenx
ARGX
$43.6B
$10.2M 3.34% 28,770 -24,030 -46% -$8.48M
SWTX
17
DELISTED
SpringWorks Therapeutics
SWTX
$8.79M 2.89% +308,092 New +$8.79M
GBTG.WS
18
DELISTED
Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
GBTG.WS
$1.43M 0.47% 913,000 – –
BTWNW
19
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$116K 0.04% 895,000 – –
ZTAQW
20
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$111K 0.04% 358,270 – –
CPAAW
21
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$104K 0.03% 571,666 – –
STRY.WS
22
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
$87K 0.03% 669,000 – –
CNDA.WS
23
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$86K 0.03% 408,333 – –
CCVI.WS
24
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$76K 0.03% 540,000 – –
CVIIW
25
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$74K 0.02% 548,000 – –
1
2 3